EMBL Australia

New research by the EMBL Australia Node in Single Molecule Science at UNSW reveals the mechanical processes used by T cells to kill cancer cells more efficiently.

A new biotech company led by Professor Peter Currie and Associate Professor Mikaël Martino, will receive more than half a million dollars to develop much-needed new therapies for the treatment of debilitating muscular dystrophies. 

A/Prof Robert Weatheritt was awarded an RNA Future Leaders grant to develop drugs to fight obesity and Dr Senthil Arumugam won a Team Science grant to further investigate cell size regulation.

Genes in the human genome are made of DNA. Upon gene expression, a segment of DNA is copied into another molecule called RNA. When gene regulation goes wrong, diseases like cancer can occur. Therefore, knowing how enzymes — highly efficient protein nanomachines — work to switch genes on and off enables the development of new drugs and diagnostics.

Research led by EMBL Australia group leader Max Cryle has revealed a key aspect of peptide machineries, advancing his work in countering the global threat of antimicrobial resistance and having broad implications for health and industry.

Research led by EMBL Australia group leader Dr Harald Janovjak has revealed the potential of optogenetics - a relatively new and rapidly evolving technology - to treat Parkinson's disease.

Dr Vaishnavi Ananthanarayanan recently joined EMBL Australia as a Group Leader, based at UNSW's Single Molecule Science.

Farewell to world-leading immunologist and molecular microscopist Scientia Professor Katharina Gaus - a visionary scientist, inspirational mentor, and much-loved friend, colleague and collaborator.

An exciting discovery by Monash University scientists - including members of EMBL Australia's leadership team, Professor Peter Currie and Associate Professor Mikaël Martino - may lead to faster recovery from muscle injury and wasting diseases.

We are excited to welcome the newest member of the EMBL Australia Council, Professor Ian Smith, who replaced the outgoing Professor Brandon Wainwright AM as chairperson, in November 2020.